ArticleInternational journal of medical sciences2016

Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin.

Tatsuo Kanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.